Becton, Dickinson and Co (XSWX:BDX) EBIT : CHF1,876 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Becton, Dickinson and Co EBIT?

Becton, Dickinson and Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was CHF674 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was CHF1,876 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Becton, Dickinson and Co's annualized ROC % for the quarter that ended in Mar. 2024 was 6.25%. Becton, Dickinson and Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 37.15%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Becton, Dickinson and Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 2.39%.

Becton, Dickinson and Co EBIT Historical Data

The historical data trend for Becton, Dickinson and Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Becton, Dickinson and Co EBIT Chart

Becton, Dickinson and Co Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

EBIT

Get a 7-Day Free Trial

1,797.94

861.84

1,994.17

2,122.77

1,901.75

Becton, Dickinson and Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial															598.80	531.24	264.48	406.46	673.56

Competitive Comparison of Becton, Dickinson and Co's EBIT

For the Medical Instruments & Supplies subindustry, Becton, Dickinson and Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Becton, Dickinson and Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Becton, Dickinson and Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Becton, Dickinson and Co's EV-to-EBIT falls into.

Becton, Dickinson and Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF1,876 Mil.

Becton, Dickinson and Co (XSWX:BDX) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Becton, Dickinson and Co's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	2967.924 * ( 1 - 15.17% )	/	( (39896.683	+	40727.203)	/ 2 )
=	2517.6899292	/	40311.943
=	6.25 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	45206.555	-	4777.155	-	( 1022.194	-	max(0, 6520.592	-	7053.309	+	1022.194	))
=	39896.683

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	48123.91	-	4719.355	-	( 2821.305	-	max(0, 6510.772	-	9188.124	+	2821.305	))
=	40727.203

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Becton, Dickinson and Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	2694.236	/	( ( (5748.326 + max(1253.96, 0))	+	(5856.763 + max(1647.465, 0)) )	/	2 )
=	2694.236	/	( ( 7002.286	+	7504.228 )	/	2 )
=	2694.236	/	7253.257
=	37.15 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1960.502	+	2857.299	+	1213.314)	-	(4777.155	+	0	+	0)
=	1253.96

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(2273.927	+	2869.289	+	1223.603)	-	(4719.355	+	0	+	-0.00099999999929423)
=	1647.465

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Becton, Dickinson and Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	1875.733	/	78370.108
	=	2.39 %

Becton, Dickinson and Co EBIT Related Terms

Thank you for viewing the detailed overview of Becton, Dickinson and Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Becton, Dickinson and Co (XSWX:BDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton, Dickinson and Co (XSWX:BDX) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

BDX:USA BDX:Mexico 1BDX:Italy BOX:Germany B1DX34:Brazil

Address

1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880

Website

https://www.bd.com

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of estimated 2023 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.